<DOC>
	<DOCNO>NCT02322723</DOCNO>
	<brief_summary>In Israel , data lacking regard long-term effectiveness Adalimumab outpatient real life set . Moreover , association long-term effectiveness Adalimumab patient ' functional status well cultural aspect sick leave visit physician 's clinic demonstrate population . This study collect require data real life setting .</brief_summary>
	<brief_title>Real Life Evaluation Rheumatoid Arthritis Patients Israel Treated With HUMIRA</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Patient eligible Adalimumab treatment accord Israeli National Health Basket decision initiate Adalimumab already take . Patients naïve Adalimumab therapy , prescribe adalimumab accordance physician 's clinical decision accord local guideline , 30 day prior screen . 2 . Patient perform tuberculosis ( TB ) screen treatment accord national guideline TB screen prior anti Tumor Necrosis Factor ( antiTNF ) treatment . 3 . Patient diagnose Rheumatoid Arthritis ( RA ) disease duration &lt; 3 year . 4 . Patient moderately severely active RA define Disease Activity Score ( DAS ) ( moderately ( 3.2 ≤ DAS ≤ 5.1 ) severely ( DAS ≥5.1 ) ) 5 . Patient able sign write informed consent . 6 . Patient treat Methotrexate ( MTX ) alone combination Disease Modifying Antirheumatic Drugs ( DMARDs ) 7 . Patient might treat another antiTNF inhibitor agent discontinue due secondary loss efficacy side effect . 1 . Patient known hypersensitivity Adalimumab , component . 2 . Patients suffer serious infection , latent TB condition prohibit use Adalimumab . 3 . Patient previous nonresponse antiTNF agent . 4 . Patients currently treat biologic therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Adalimumab</keyword>
	<keyword>real life</keyword>
	<keyword>RA</keyword>
	<keyword>Humira</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>effectiveness</keyword>
</DOC>